Maryam Hasanova

Maryam is a final-year Biomedical Sciences student at University College London, where her research focuses on treatment resistance in prostate cancer and immune-based recognition strategies. She is the former co-founder of OncoFlow, a health AI start-up where she partnered with the UK’s MHRA and NHS to develop explainable cancer AI platforms for clinical care. Maryam is passionate about translational medicine, biotech and AI innovation, and venture capital at the intersection of science and entrepreneurship.